Trials / Completed
CompletedNCT02127320
Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the pharmacokinetic drug interactions between Rosuvastatin and Ezetimibe in Healthy Male Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin 20mg | |
| DRUG | Ezetimibe 10mg | |
| DRUG | Rosuvastatin 20mg + Ezetimibe 10mg |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2014-09-01
- Completion
- 2014-11-01
- First posted
- 2014-04-30
- Last updated
- 2016-10-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02127320. Inclusion in this directory is not an endorsement.